Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis

Introduction Heart transplantation is the best treatment for end-stage dilated cardiomyopathy (DCM). Left ventricular assist device (LVAD) support is becoming more prevalent and may delay heart transplantation. Gene expression of the left ventricular myocardium usually changes following LVAD implantation. In this study, we aimed to identify potential biomarkers to determine the prognosis of patients with DCM after receiving LVAD support. Methods We extracted microarray datasets from Gene Expression Omnibus (GEO), including GSE430 and GSE21610. There were 28 paired DCM samples in the GSE430 and GSE21610 profiles. Differentially expressed genes (DEGs) were identified at LVAD implantation and heart transplantation. DEGs were annotated according to Gene Ontology (GO) and analyzed according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. A protein–protein interaction (PPI) network was constructed. The top 10 crucial genes were predicted using Cytoscape plugin CytoHubba in conformity with the network degree algorithm. The levels of gene expression and the diagnostic values of crucial genes were confirmed in the clinical datasets. Results The 28 DEGs were clustered into the GSE datasets. GO annotations and KEGG pathway enrichment analyses revealed that inflammation might be involved. They were associated with correlative inflammation. Combined with PPI networks, these results revealed CytoHubba's top 10 hub genes, including CCL2, CXCL12, CXCL1, CTGF/CCN2, CX3CR1, POSTN, FKBP5, SELE, AIF1, and BMP2. Among them, CCL2, CXCL12, FKBP5, and BMP2 might be considered prognostic and diagnostic biomarkers after LVAD support and have confirmed their validity in clinical datasets. The area under the curve of the four main hub genes was more than 0.85, indicating high diagnostic ability and good prognosis for patients with DCM with LVAD implantation. However, a significant effect of CCL2, CXCL12, FKBP5, and BMP2 expression was not observed on the left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), cardiac index (CI), or support time of LVAD. Conclusion CCL2, CXCL12, FKBP5, and BMP2 could be potential gene biomarkers for patients with DCM after LVAD support. These findings provide critical clues for the therapeutic management of patients with DCM and LVADs. LVEDD, LVEF, CI, and support time of LVAD were not correlated with the expression of these hub genes.

[1]  Tonglian Wang,et al.  Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform , 2022, iMeta.

[2]  Yandong Miao,et al.  Microarray analysis to explore the effect of CXCL12 isoforms in a pancreatic pre-tumor cell model , 2021, World journal of gastroenterology.

[3]  R. Ashley,et al.  CXCL12 May Drive Inflammatory Potential in the Ovine Corpus Luteum During Implantation , 2021, Reproductive Sciences.

[4]  B. Vastrad,et al.  Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis , 2021, bioRxiv.

[5]  M. Rafeeq,et al.  Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate , 2021, Annals of medicine.

[6]  J. Kzhyshkowska,et al.  Serum Levels of Bone Morphogenetic Proteins 2 and 4 in Patients with Acute Myocardial Infarction , 2020, Cells.

[7]  Margaret H. Frank,et al.  TBtools - an integrative toolkit developed for interactive analyses of big biological data. , 2020, Molecular plant.

[8]  Junmeng Zheng,et al.  Effects of Left Ventricular Assist Device on Heart Failure Patients: A Bioinformatics Analysis. , 2019, Artificial organs.

[9]  G. Pelosi,et al.  Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies , 2019, Journal of experimental & clinical cancer research : CR.

[10]  C. Gieger,et al.  Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk , 2019, Proceedings of the National Academy of Sciences.

[11]  M. Morshuis,et al.  The role of long-term mechanical circulatory support in the treatment of end-stage heart failure. , 2019, Kardiologia polska.

[12]  M. Senni,et al.  Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta‐analysis of observational studies , 2017, European journal of heart failure.

[13]  L. Gullestad,et al.  Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans , 2017, Scandinavian journal of clinical and laboratory investigation.

[14]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[15]  G. Vunjak‐Novakovic,et al.  Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature , 2016, Expert review of medical devices.

[16]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  V. Rao,et al.  Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices. , 2015, The Canadian journal of cardiology.

[18]  Laurent Excoffier,et al.  Evidence for polygenic adaptation to pathogens in the human genome. , 2013, Molecular biology and evolution.

[19]  Hendrik Milting,et al.  Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support. , 2010, Physiological genomics.

[20]  N. Frangogiannis,et al.  Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes , 2009, Current atherosclerosis reports.

[21]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[22]  D. Burkhoff,et al.  Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. , 2008, Progress in biophysics and molecular biology.

[23]  M. Yacoub,et al.  Left ventricular assist device-induced molecular changes in the failing myocardium , 2008, Current opinion in cardiology.

[24]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[25]  B. Rollins,et al.  CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.

[26]  Christian von Mering,et al.  STRING: known and predicted protein–protein associations, integrated and transferred across organisms , 2004, Nucleic Acids Res..

[27]  L. Miller,et al.  Alterations of gene expression in failing myocardium following left ventricular assist device support. , 2003, Physiological genomics.

[28]  W. Koch,et al.  Differential gene expression and genomic patient stratification following left ventricular assist device support. , 2003, Journal of the American College of Cardiology.

[29]  Christian von Mering,et al.  STRING: a database of predicted functional associations between proteins , 2003, Nucleic Acids Res..

[30]  B. Snel,et al.  STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. , 2000, Nucleic acids research.

[31]  R. Bolman,et al.  Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. , 2000, The Annals of thoracic surgery.

[32]  V. Fuster,et al.  Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.